John Overdeck’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.46M | Sell |
718,550
-482,719
| -40% | -$1.5M | ﹤0.01% | 2810 |
|
|
2026
Q1 | $2.74M | Buy |
1,201,269
+19,601
| +2% | +$45.1K | ﹤0.01% | 2511 |
|
|
2025
Q4 | $3.31M | Buy |
1,181,668
+122,297
| +12% | +$437K | ﹤0.01% | 2072 |
|
|
2025
Q3 | $5.08M | Buy |
1,059,371
+356,653
| +51% | +$2.27M | 0.01% | 1449 |
|
|
2025
Q2 | $6.39M | Buy |
702,718
+315,473
| +81% | +$2.32M | 0.01% | 1091 |
|
|
2025
Q1 | $3.5M | Buy |
387,245
+324,304
| +515% | +$3.42M | 0.01% | 1340 |
|
|
2024
Q4 | $823K | Sell |
62,941
-29,689
| -32% | -$396K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $1.45M | Buy |
92,630
+74,707
| +417% | +$1.13M | ﹤0.01% | 1878 |
|
|
2024
Q2 | $242K | Sell |
17,923
-133,445
| -88% | -$2.73M | ﹤0.01% | 2672 |
|
|
2024
Q1 | $4.19M | Sell |
151,368
-366,438
| -71% | -$8.14M | 0.01% | 1068 |
|
|
2023
Q4 | $9.98M | Sell |
517,806
-66,527
| -11% | -$1.2M | 0.02% | 678 |
|
|
2023
Q3 | $9.44M | Buy |
584,333
+301,070
| +106% | +$5.34M | 0.03% | 624 |
|
|
2023
Q2 | $5.39M | Buy |
283,263
+123,009
| +77% | +$2.19M | 0.01% | 895 |
|
|
2023
Q1 | $2.33M | Buy |
160,254
+140,254
| +701% | +$2.51M | 0.01% | 1287 |
|
|
2022
Q4 | $391K | Buy |
+20,000
| New | +$390K | ﹤0.01% | 2126 |
|
|
2021
Q3 | – | Sell |
-101,054
| Closed | -$3.98M | – | 4570 |
|
|
2021
Q2 | $4.28M | Buy |
101,054
+79,935
| +378% | +$3.11M | 0.01% | 1297 |
|
|
2021
Q1 | $794K | Sell |
21,119
-97,490
| -82% | -$3.05M | ﹤0.01% | 2527 |
|
|
2020
Q4 | $3.21M | Buy |
118,609
+64,087
| +118% | +$1.65M | 0.01% | 1191 |
|
|
2020
Q3 | $1.37M | Buy |
+54,522
| New | +$795K | ﹤0.01% | 1553 |
|
|
2020
Q1 | – | Sell |
-30,188
| Closed | -$156K | – | 3644 |
|
|
2019
Q4 | $156K | Sell |
30,188
-195,832
| -87% | -$1.26M | ﹤0.01% | 3470 |
|
|
2019
Q3 | $1.31M | Sell |
226,020
-366,614
| -62% | -$1.64M | ﹤0.01% | 1754 |
|
|
2019
Q2 | $1.9M | Buy |
592,634
+259,993
| +78% | +$887K | 0.01% | 1475 |
|
|
2019
Q1 | $1.36M | Buy |
+332,641
| New | +$2.1M | ﹤0.01% | 1642 |
|
|
2018
Q4 | – | Sell |
-95,987
| Closed | -$1.59M | – | 3377 |
|
|
2018
Q3 | $1.59M | Sell |
95,987
-208,121
| -68% | -$3.54M | ﹤0.01% | 1641 |
|
|
2018
Q2 | $5.08M | Sell |
304,108
-100,707
| -25% | -$1.63M | 0.02% | 1010 |
|
|
2018
Q1 | $6.29M | Sell |
404,815
-440,865
| -52% | -$7.86M | 0.02% | 828 |
|
|
2017
Q4 | $16M | Buy |
+845,680
| New | +$18.8M | 0.05% | 430 |
|
|
2017
Q3 | – | Sell |
-33,869
| Closed | -$1.09M | – | 3076 |
|
|
2017
Q2 | $1.09M | Sell |
33,869
-73,219
| -68% | -$2.4M | ﹤0.01% | 1842 |
|
|
2017
Q1 | $3.71M | Sell |
107,088
-210,668
| -66% | -$7.52M | 0.01% | 1091 |
|
|
2016
Q4 | $11.2M | Buy |
317,756
+173,563
| +120% | +$5.86M | 0.04% | 494 |
|
|
2016
Q3 | $5.01M | Buy |
144,193
+53,048
| +58% | +$1.86M | 0.02% | 875 |
|
|
2016
Q2 | $3.41M | Buy |
91,145
+54,421
| +148% | +$2.05M | 0.01% | 959 |
|
|
2016
Q1 | $1.48M | Buy |
+36,724
| New | +$1.37M | 0.01% | 1366 |
|
|
2015
Q3 | – | Sell |
-11,929
| Closed | -$406K | – | 2574 |
|
|
2015
Q2 | $406K | Buy |
+11,929
| New | +$402K | ﹤0.01% | 2236 |
|
|
2015
Q1 | – | Sell |
-40,486
| Closed | -$1.42M | – | 2788 |
|
|
2014
Q4 | $1.42M | Buy |
+40,486
| New | +$1.36M | 0.01% | 1200 |
|
|
2014
Q3 | – | Sell |
-25,946
| Closed | -$882K | – | 1965 |
|
|
2014
Q2 | $882K | Sell |
25,946
-100,404
| -79% | -$3.44M | ﹤0.01% | 1379 |
|
|
2014
Q1 | $4.43M | Buy |
+126,350
| New | +$4.46M | 0.02% | 676 |
|
|
2013
Q3 | – | Sell |
-12,200
| Closed | -$413K | – | 2031 |
|
|
2013
Q2 | $413K | Buy |
+12,200
| New | +$405K | ﹤0.01% | 1502 |
|
Other funds holding ACH
CCM
ICM
PCMI
John Overdeck's ACH Position: Q2 2026 in Review
John Overdeck reduced its Accendra Health (ACH) stake by 40% in Q2 2026, selling an estimated $1.5M and leaving 718,550 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2810.
John Overdeck first reported a position in ACH in Q2 2013 and has held it in 38 quarters since. The position peaked at $16M in Q4 2017. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- John Overdeck held 718,550 shares of Accendra Health worth $2.46M as of Q2 2026.
- John Overdeck sold 482,719 Accendra Health shares in Q2 2026, an estimated $1.5M.
- Accendra Health made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2810 holding.
- John Overdeck first reported a position in Accendra Health in Q2 2013 and has held it in 38 quarters since.
- John Overdeck's Accendra Health position peaked at $16M in Q4 2017.
- 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.